Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease

[1]  M. Ruel,et al.  Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting? , 2020, Journal of cardiac failure.

[2]  R. Leyh,et al.  Atrial contractility and fibrotic biomarkers are associated with atrial fibrillation after elective coronary artery bypass grafting. , 2020, The Journal of thoracic and cardiovascular surgery.

[3]  U. Aksu,et al.  Assessment of right ventricular dysfunction in patients with mitral stenosis: A speckle tracking study , 2019, Journal of clinical ultrasound : JCU.

[4]  Y. Kim,et al.  Tricuspid annular diameter and right ventricular volume on preoperative cardiac CT can predict postoperative right ventricular dysfunction in patients who undergo tricuspid valve surgery. , 2019, International journal of cardiology.

[5]  B. Allen.  Myocardial protection: a forgotten modality. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  A. Mohammadzadeh,et al.  Right ventricular dysfunction and associated factors in patients after coronary artery bypass grafting , 2019, ARYA atherosclerosis.

[7]  R. Leyh,et al.  Impact of diabetes mellitus on the contractile properties of the left and right atrial myofilaments† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  M. Isobe,et al.  Right ventricular dysfunction is associated with exercise intolerance and poor prognosis in ischemic heart disease , 2018, Heart and Vessels.

[9]  M. Mathier,et al.  Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension , 2018, Clinical cardiology.

[10]  B. Bozkurt,et al.  Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association , 2018, Circulation.

[11]  W. Rathmann,et al.  Subclinical changes in MRI-determined right ventricular volumes and function in subjects with prediabetes and diabetes , 2018, European Radiology.

[12]  I. V. Van Gelder,et al.  Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation. , 2017, Journal of cardiac failure.

[13]  S. Russell,et al.  Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function. , 2017, The American journal of cardiology.

[14]  L. Allam,et al.  Right Ventricular Outflow Tract Systolic Excursion and Fractional Shortening: Can These Echocardiographic Parameters be Used for the Assessment of Right Ventricular Function? , 2017, Journal of cardiovascular echography.

[15]  R. Levine,et al.  Right Ventricular Dysfunction Impairs Effort Tolerance Independent of Left Ventricular Function Among Patients Undergoing Exercise Stress Myocardial Perfusion Imaging , 2016, Circulation. Cardiovascular imaging.

[16]  S. Flamm,et al.  Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy , 2016, Circulation.

[17]  R. Leyh,et al.  Right atrial contractile dynamics are impaired in patients with postcapillary pulmonary hypertension. , 2016, Experimental and therapeutic medicine.

[18]  S. Brener,et al.  Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery , 2015, PloS one.

[19]  G. Kocabay,et al.  Right heart mechanics in untreated normotensive patients with prediabetes and type 2 diabetes mellitus: a two- and three-dimensional echocardiographic study. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  Amit R. Patel,et al.  Beyond right ventricular size and function: the importance of evaluating the right ventricle’s capacity for recovery , 2014, Expert review of cardiovascular therapy.

[21]  L. Tavazzi,et al.  Pentraxin‐3 in chronic heart failure: the CORONA and GISSI‐HF trials , 2012, European journal of heart failure.

[22]  Qiming Liu,et al.  Pentraxin 3 as a new biomarker of diastolic dysfunction. , 2011, International journal of cardiology.

[23]  P. Home,et al.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease , 2010, Current cardiology reviews.

[24]  G. Biolo,et al.  Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile , 2009, Clinical and Experimental Medicine.

[25]  D. Fliser,et al.  Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Henein,et al.  Right ventricular outflow-tract fractional shortening: an applicable measure of right ventricular systolic function. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[27]  M. Regan,et al.  Precardiopulmonary Bypass Right Ventricular Function Is Associated with Poor Outcome After Coronary Artery Bypass Grafting in Patients with Severe Left Ventricular Systolic Dysfunction , 2002, Anesthesia and analgesia.

[28]  M. Frenneaux,et al.  Prognostic importance of right ventricular dysfunction , 2002, Heart.

[29]  J. Gulati,et al.  Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. , 1995, Circulation research.

[30]  M. Böhm,et al.  Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. , 1990, Journal of molecular and cellular cardiology.

[31]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  P. Mateo,et al.  Functional tissue and developmental specificities of myofibrils and mitochondria in cardiac muscle. , 1996, Canadian journal of physiology and pharmacology.